Aktienkurs
181,14
$
-34,85
16,14 %1 M.
-50,18
21,69 %6 M.
-92,44
33,79 %YTD
-58,40
24,38 %1 J.
+31,76
21,26 %3 J.
+86,14
90,67 %5 J.
+139,03
330,16 %10 J.
NYSE,
Schlusskurs Fr, 30.09.2022
Powered by
ISIN
US46266C1053
Symbol
IQV
Index
Sektor
Industrie
Kennzahlen
BETA
BETA
| Marktkapitalisierung | 33,78 Mrd. USD |
| Enterprise Value | 45,32 Mrd. USD |
| KGV (TTM) KGV | 30,25 |
| EV/FCF (TTM) EV/FCF | 26,83 |
| EV/Sales (TTM) EV/Sales | 3,20 |
| KUV (TTM) KUV | 2,39 |
| KBV (TTM) KBV | 6,32 |
| Umsatzwachstum (TTM) Umsatzwachstum | 9,49 % |
| Umsatz (TTM) Umsatz | 14,15 Mrd. USD |
Mehr anzeigen
Finanzdaten von IQVIA
| Jun. '22 |
+/-
%
|
||
| Umsatz | 14.147 14.147 |
9 %
9 %
|
|
| Bruttoertrag | 3.753 3.753 |
25 %
25 %
|
|
| EBITDA | 2.865 2.865 |
17 %
17 %
|
EBIT (Operatives Ergebnis) EBIT | 1.742 1.742 |
54 %
54 %
|
| Nettogewinn | 1.160 1.160 |
91 %
91 %
|
|
Angaben in Millionen USD.
IQVIA Aktie News
Seeking Alpha
12 Tage alt
|
Neutral
IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)
IQVIA Holdings Inc. bottomed on June 16 and has since rallied 28% in a breakout attempt that finally failed. IQVIA Holdings stock is a strong leader in its industry, and despite some recent weakness, has significantly outperformed the broader healthcare sector.
IQVIA Holdings Inc. bottomed on June 16 and has since rallied 28% in a breakout attempt that finally failed. IQVIA Holdings stock is a strong leader in its industry, and despite some recent weakness, has significantly outperformed the broader healthcare sector.
Seeking Alpha
2 Monate alt
|
Positiv
IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same
Earnings quality and resiliency were on full display last quarter for IQVIA. The company continues to compound FCF at a long-term geometric average of 23%, with equally as high FCF ROE.
Earnings quality and resiliency were on full display last quarter for IQVIA. The company continues to compound FCF at a long-term geometric average of 23%, with equally as high FCF ROE.
Seeking Alpha
2 Monate alt
|
Neutral
IQVIA Holdings (IQV) CEO, Ari Bousbib on Q2 2022 Results - Earnings Call Transcript
IQVIA Holdings Inc. (NYSE:IQV ) Q2 2022 Earnings Conference Call July 21, 2022 9:00 AM ET Company Participants Ari Bousbib - Chairman, Chief Executive Officer Ron Bruehlman - Executive Vice President, Chief Financial Officer Mike Fedock - Senior Vice President, Financial Planning and Analysis Nick Childs - Senior Vice President, Investor Relations and Corporate Communications Conference Call Pa...
IQVIA Holdings Inc. (NYSE:IQV ) Q2 2022 Earnings Conference Call July 21, 2022 9:00 AM ET Company Participants Ari Bousbib - Chairman, Chief Executive Officer Ron Bruehlman - Executive Vice President, Chief Financial Officer Mike Fedock - Senior Vice President, Financial Planning and Analysis Nick Childs - Senior Vice President, Investor Relations and Corporate Communications Conference Call Pa...
Firmenprofil
Bietet biopharmazeutische Entwicklungsdienste und kommerzielle Outsourcing-Dienstleistungen
| Hauptsitz | USA |
| CEO | Ari Bousbib |
| Mitarbeiter | 79.000 |
| Gegründet | 1982 |
| Webseite | www.iqvia.com |
aktien.guide Premium
Mit dem Premium Zugang erhältst Du sämtliche Funktionen von aktien.guide uneingeschränkt mit Realtime-Kursen für 6.923 weltweite Aktien - auf komplett werbefreien Seiten.
* bei jährlicher Zahlung